7Baggers
 price to earnings forward of lava therapeutics nv – ls:a2qsjy  TradingView Sat, 27 Jun 2026 05:22:02 GMT
 LAVA Therapeutics NV Actuals & Estimates (LS:A2QSJY)  TradingView Fri, 26 Jun 2026 03:02:46 GMT
 LAVA Therapeutics NV (LVTX) Institutional Confidence  TradingKey Thu, 18 Jun 2026 03:03:43 GMT
 hairy cell leukemia therapeutics market size (7mm)  openPR.com Wed, 13 May 2026 09:30:32 GMT
 tradingkey  TradingKey Tue, 12 May 2026 21:48:06 GMT
 Cytospire raises £61M to take gamma-delta T-cell engager into the clinic  European Biotechnology Magazine Tue, 05 May 2026 07:00:00 GMT
 Ligand snaps up fellow biotech royalty aggregator Xoma for $739M  Fierce Pharma Mon, 27 Apr 2026 07:00:00 GMT
 Thermo Fisher sells microbiology biz; Ligand to buy XOMA  Endpoints News Mon, 27 Apr 2026 07:00:00 GMT
 prelude therapeutics prices $90m stock offering at $4.44/share  Investing.com Mon, 20 Apr 2026 07:00:00 GMT
 xoma sec filings - xoma royalty corporation 10-k, 10-q, 8-k forms  Stock Titan Thu, 02 Apr 2026 09:47:39 GMT
 published on: 2026-03-29 23:39:14  baoquankhu1.vn Sun, 29 Mar 2026 16:39:38 GMT
 if you invested $1,000 in lava therapeutics n.v. (lvtx)  Stock Titan Wed, 25 Mar 2026 09:27:18 GMT
 tencent: the premier hunter of medical ipos  36 Kr Mon, 23 Mar 2026 07:00:00 GMT
 if you invested $1,000 in lava therapeutics n.v. (lvtx)  Stock Titan Sun, 22 Mar 2026 11:59:13 GMT
 Tencent: The Premier Hunter of Medical IPOs  36 Kr Sun, 22 Mar 2026 07:00:00 GMT
 lisata therapeutics shares up 20% as kuva labs acquisition advances  Yahoo Finance Mon, 09 Mar 2026 07:00:00 GMT
 lvtx stock news today | earnings, events & price alerts  Intellectia AI Sat, 28 Feb 2026 06:14:48 GMT
 lava therapeutics approves merger with new topco b.v.  MSN Wed, 28 Jan 2026 23:35:02 GMT
 Top startups in Cell Therapy in Europe (Jan, 2026)  Tracxn Thu, 08 Jan 2026 08:00:00 GMT
 published on: 2025-12-20 11:31:17  Улправда Sat, 20 Dec 2025 07:31:17 GMT
 published on: 2025-12-18 13:21:42  Улправда Thu, 18 Dec 2025 09:21:42 GMT
 novel t-cell immunotherapies market share, size, growth and forecast to 2034  Insightace Analytic Wed, 17 Dec 2025 08:00:00 GMT
 ‘Zombie’ biotech buyer Xoma to acquire Generation Bio  Yahoo Finance Tue, 16 Dec 2025 08:00:00 GMT
 xoma royalty expands portfolio through mural oncology acquisition  AD HOC NEWS Sun, 07 Dec 2025 08:00:00 GMT
 total debt per share of lava therapeutics nv – ber:4pkb  TradingView Fri, 05 Dec 2025 01:00:05 GMT
 operating cash flow per share of lava therapeutics nv – swb:4pkb  TradingView Thu, 04 Dec 2025 20:22:35 GMT
 is lava therapeutics nv overvalued or undervalued?  Markets Mojo Tue, 02 Dec 2025 21:54:57 GMT
 lava therapeutics (lvtx) expected to announce earnings on tuesday  Defense World Tue, 02 Dec 2025 06:52:46 GMT
 Xoma completes $24.9M acquisition of cash-strapped Lava Therapeutics  The Business Journals Mon, 24 Nov 2025 08:00:00 GMT
 lava therapeutics delists from nasdaq and changes leadership  The Globe and Mail Sat, 22 Nov 2025 08:00:00 GMT
 xoma royalty corporation completes acquisition of lava therapeutics n.v.  Quiver Quantitative Fri, 21 Nov 2025 08:00:00 GMT
 xoma royalty completes acquisition of lava therapeutics by investing.com  Investing.com South Africa Fri, 21 Nov 2025 08:00:00 GMT
 xoma completes acquisition of lava therapeutics  TipRanks Fri, 21 Nov 2025 08:00:00 GMT
 lava therapeutics delists from nasdaq and changes leadership  TipRanks Fri, 21 Nov 2025 08:00:00 GMT
 xoma completes lvtx tender; nasdaq delisting and form 15 planned  Stock Titan Fri, 21 Nov 2025 08:00:00 GMT
 lava therapeutics announces executive departures  TradingView Fri, 21 Nov 2025 08:00:00 GMT
 xoma royalty finalizes lava acquisition, paying $1.04 plus cvr  Stock Titan Fri, 21 Nov 2025 08:00:00 GMT
 lava intents to delist from nasdaq  MSN Thu, 20 Nov 2025 19:16:06 GMT
 will lava therapeutics n.v. (4pkb) stock justify high valuation  newser.com Thu, 20 Nov 2025 05:28:18 GMT

LAVA Therapeutics N.V.
(NASDAQ:LVTX) 

LVTX stock logo

Lava Therapeutics B.V., a biotechnology company, engages in developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its platform. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/...

Founded: 2016
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends